A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Sanwa Kagaku Kenkyusho Co., Ltd.

Overview

This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone for the treatment of macular edema associated with branch retinal vein occlusion.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Macular Degeneration Macular Edema Branch Retinal Vein Occlusion

Interventions

dexamethasoneDRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Macular edema resulting from branch retinal vein condition * The criteria for visual acuity and macular thickness are met Exclusion Criteria: * History of glaucoma * Diabetic retinopathy * Known steroid-responder * Use of systemic steroids * Use of Warfarin/Heparin

Locations (12)

Unnamed facility

Aichi, Japan

Unnamed facility

Chiba, Japan

Unnamed facility

Fukuoka, Japan

Unnamed facility

Gunma, Japan

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.